• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

发育性神经转录因子在弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)中的表达

Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).

作者信息

Escudero Antonio García, Zarco Enrique Rodríguez, Arjona Juan Carlos Girón, Moreno María José Ríos, Rodríguez Katherine Gallardo, Benítez Ana Vallejo, Cámpora Ricardo González

机构信息

Department of Anatomic Pathology, "Virgen Macarena" University Hospital, Avda, Doctor Fedriani s/n, Seville, 41009, Spain.

Department of Thoracic Surgery, "Virgen Macarena" University Hospital, Seville, Spain.

出版信息

Virchows Arch. 2016 Sep;469(3):357-63. doi: 10.1007/s00428-016-1962-5. Epub 2016 Jun 14.

DOI:10.1007/s00428-016-1962-5
PMID:27300020
Abstract

DIPNECH is characterized by neuroendocrine cell hyperplasia, tumorlets, and eventually carcinoid tumors. Although it is regarded by some authors as a preneoplastic condition, this issue is controversial. New pathologic criteria have recently been proposed for the diagnosis of DIPNECH, and a subgroup of carcinoid tumors expressing developing neural transcription factors (DNTFs), with clinicopathologic features similar to those of DIPNECH, has been recognized. This paper reports on the clinical and pathological findings in three cases of DIPNECH and investigates the expression of three DNTFs (TTF1, ASCL1, and POU3F2). All patients were female, with a mean age of 63 years, and all lesions were located in the periphery of the lung. In two cases, typical carcinoids were associated with a spindle-cell component. All neuroendocrine proliferations were DNTF positive. The morphologic (spindle-cell component), phenotypic (DNTF expression), and clinicopathologic (peripheral tumors, female predominance) similarities suggest that DIPNECH may be a preneoplastic lesion for peripheral carcinoids.

摘要

弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)的特征为神经内分泌细胞增生、微瘤,最终发展为类癌肿瘤。尽管一些作者认为它是一种癌前病变,但这一问题存在争议。最近已提出用于诊断DIPNECH的新病理标准,并且已识别出一组表达发育性神经转录因子(DNTF)的类癌肿瘤,其临床病理特征与DIPNECH相似。本文报告了3例DIPNECH的临床和病理结果,并研究了三种DNTF(TTF1、ASCL1和POU3F2)的表达情况。所有患者均为女性,平均年龄63岁,所有病变均位于肺外周。在2例病例中,典型类癌伴有梭形细胞成分。所有神经内分泌增殖均为DNTF阳性。形态学(梭形细胞成分)、表型(DNTF表达)和临床病理(外周肿瘤、女性为主)的相似性表明,DIPNECH可能是外周类癌的癌前病变。

相似文献

1
Expression of developing neural transcription factors in diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).发育性神经转录因子在弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)中的表达
Virchows Arch. 2016 Sep;469(3):357-63. doi: 10.1007/s00428-016-1962-5. Epub 2016 Jun 14.
2
The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?多灶性肺神经内分泌增生的成人患者的病变谱:诊断弥漫性特发性肺神经内分泌细胞增生症的最小病理标准集是什么?
Hum Pathol. 2015 Feb;46(2):176-81. doi: 10.1016/j.humpath.2014.10.019. Epub 2014 Nov 12.
3
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: Imaging and Clinical Features of a Frequently Delayed Diagnosis.弥漫性特发性肺神经内分泌细胞增生症:常被延误诊断的影像学和临床特征。
AJR Am J Roentgenol. 2020 Dec;215(6):1312-1320. doi: 10.2214/AJR.19.22628. Epub 2020 Oct 6.
4
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH):当前最佳证据
Lung. 2015 Oct;193(5):659-67. doi: 10.1007/s00408-015-9755-1. Epub 2015 Jun 24.
5
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)综合征与类癌肿瘤伴/不伴 NECH:一项临床病理、放射学和免疫分子比较研究。
Am J Surg Pathol. 2018 May;42(5):646-655. doi: 10.1097/PAS.0000000000001033.
6
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity.弥漫性特发性肺神经内分泌细胞增生和相关肺神经内分泌肿瘤:罕见实体的临床经验。
Cancer. 2012 Feb 1;118(3):612-9. doi: 10.1002/cncr.26200. Epub 2011 Jul 12.
7
Lung carcinoid tumors with Diffuse Idiopathic Pulmonary NeuroEndocrine Cell Hyperplasia (DIPNECH) exhibit pejorative pathological features.具有弥漫性特发性肺神经内分泌细胞增生(DIPNECH)的肺类癌肿瘤表现出不良的病理特征。
Lung Cancer. 2021 Jun;156:117-121. doi: 10.1016/j.lungcan.2021.04.024. Epub 2021 Apr 30.
8
Association of small foci of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) with adenocarcinoma of the lung.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH)小灶与肺癌腺癌的相关性。
Pathol Res Pract. 2013 Sep;209(9):578-84. doi: 10.1016/j.prp.2013.06.019. Epub 2013 Jul 12.
9
DIPNECH: pragmatic approach, uncertainties, notable associations, and a proposal for an improved definition.DIPNECH:务实的方法、不确定性、显著关联,以及对改进定义的建议。
Endocr Relat Cancer. 2023 Aug 16;30(10). doi: 10.1530/ERC-23-0051. Print 2023 Oct 1.
10
[Pulmonary neuroendocrine tumors and preneoplasic lesions].[肺神经内分泌肿瘤和肿瘤前病变]
Ann Pathol. 2016 Jan;36(1):34-43. doi: 10.1016/j.annpat.2015.11.008. Epub 2016 Jan 5.

引用本文的文献

1
Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors.肺神经内分泌肿瘤新型预后及潜在预测生物标志物的见解
Cancer Genomics Proteomics. 2018 Mar-Apr;15(2):153-163. doi: 10.21873/cgp.20073.
2
Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.神经内分泌肺部肿瘤的低、中、高级别:解剖病理学诊断-预后和预测因素。
Mol Diagn Ther. 2018 Apr;22(2):169-177. doi: 10.1007/s40291-018-0315-2.

本文引用的文献

1
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia of the Lung (DIPNECH): Current Best Evidence.弥漫性特发性肺神经内分泌细胞增生症(DIPNECH):当前最佳证据
Lung. 2015 Oct;193(5):659-67. doi: 10.1007/s00408-015-9755-1. Epub 2015 Jun 24.
2
Recent advances in histogenesis research of lung neuroendocrine cancers: Evidence obtained from functional analyses of primitive neural/neuroendocrine cell-specific transcription factors.肺神经内分泌癌组织发生学研究的最新进展:从原始神经/神经内分泌细胞特异性转录因子功能分析中获得的证据
Pathol Int. 2015 Jun;65(6):277-85. doi: 10.1111/pin.12267. Epub 2015 Feb 24.
3
The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?
多灶性肺神经内分泌增生的成人患者的病变谱:诊断弥漫性特发性肺神经内分泌细胞增生症的最小病理标准集是什么?
Hum Pathol. 2015 Feb;46(2):176-81. doi: 10.1016/j.humpath.2014.10.019. Epub 2014 Nov 12.
4
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.ASCL1是一种谱系癌基因,为高级别神经内分泌肺癌提供治疗靶点。
Proc Natl Acad Sci U S A. 2014 Oct 14;111(41):14788-93. doi: 10.1073/pnas.1410419111. Epub 2014 Sep 29.
5
Class III/IV POU transcription factors expressed in small cell lung cancer cells are involved in proneural/neuroendocrine differentiation.在小细胞肺癌细胞中表达的III/IV类POU转录因子参与神经源性/神经内分泌分化。
Pathol Int. 2014 Sep;64(9):415-22. doi: 10.1111/pin.12198.
6
Expression of developing neural transcription factors in lung carcinoid tumors.发育神经转录因子在肺类癌肿瘤中的表达。
Pathol Int. 2014 Aug;64(8):365-74. doi: 10.1111/pin.12183.
7
Differences of molecular expression mechanisms among neural cell adhesion molecule 1, synaptophysin, and chromogranin A in lung cancer cells.神经细胞黏附分子 1、突触素和嗜铬粒蛋白 A 在肺癌细胞中的分子表达机制差异。
Pathol Int. 2012 Apr;62(4):232-45. doi: 10.1111/j.1440-1827.2011.02781.x. Epub 2012 Jan 13.
8
MYBPH, a transcriptional target of TTF-1, inhibits ROCK1, and reduces cell motility and metastasis.MYBPH 是 TTF-1 的一个转录靶标,它可以抑制 ROCK1,从而降低细胞的迁移和转移能力。
EMBO J. 2012 Jan 18;31(2):481-93. doi: 10.1038/emboj.2011.416. Epub 2011 Nov 15.
9
Morphology and antigen expression profile of pulmonary neuroendocrine cells in reactive proliferations and diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH).反应性增殖和弥漫性特发性肺神经内分泌细胞增生(DIPNECH)中肺神经内分泌细胞的形态和抗原表达谱。
Histopathology. 2011 Oct;59(4):751-62. doi: 10.1111/j.1365-2559.2011.03992.x.
10
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer.miR-375 通过 ASH1 激活,并以谱系依赖的方式抑制肺癌中的 YAP1。
Cancer Res. 2011 Oct 1;71(19):6165-73. doi: 10.1158/0008-5472.CAN-11-1020. Epub 2011 Aug 19.